Tedizolid Phosphate Tablet, Coated
NDC Package 66406-0206-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Tedizolid Phosphate tablets is a medication used to treat serious bacterial infections of the skin. This formulation utilizes a tablet, coated delivery system. Marketed by Patheon Inc., this product is identified by NDC 66406-0206.

Identification & Billing

NDC Package Code
66406-0206-3
Package Description
90 BLISTER PACK in 1 CONTAINER / 1 TABLET, COATED in 1 BLISTER PACK
Product Code
66406-0206
11-Digit Billing Format
66406020603

Clinical Specifications

Proprietary Name
Tedizolid Phosphate
Non-Proprietary Name
Tedizolid Phosphate
Substance Name
Tedizolid Phosphate
Dosage Form
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Active Ingredient(s)
TEDIZOLID PHOSPHATE 200 mg/1
Usage Information
This medication is used to treat serious bacterial infections of the skin. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Regulatory & Marketing

Labeler Name
Patheon Inc.
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
06-20-2014
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (66406-0206). Click a package code to view its specific billing and regulatory data.

66406-0206-1
96 BOTTLE in 1 CONTAINER / 30 TABLET, COATED in 1 BOTTLE
66406-0206-2
90 BLISTER PACK in 1 CONTAINER / 6 TABLET, COATED in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66406-0206-3 identifies a specific commercial package of 90 blister pack in 1 container / 1 tablet, coated in 1 blister pack of Tedizolid Phosphate (UNFINISHED drug), drug for further processing labeled by Patheon Inc.. This tablet, coated is formulated for use and contains tedizolid phosphate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Patheon Inc. on June 20, 2014. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat serious bacterial infections of the skin. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

How is this Patheon Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66406020603. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
66406-0206-3
11-Digit CMS (5-4-2)
66406-0206-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.